Healthcare Industry News Weekly Wrap-Up: March 7, 2024
// Biotech and Pharma Therapeutics RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds March 4, 2024 / RSV / Pfizer / GSK / Arexvy After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s...
